Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 40.34% is 282% above its 5-year average of -22.19%, near the high end of its 5-year range (-699.18%–61.49%).
20.32% below its 12-month average of 50.63%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 61.49%.
EBITDA MARGIN
40.34%
EBITDA MARGIN AVG TTM
50.63%
EBITDA MARGIN AVG 3Y
16.01%
EBITDA MARGIN AVG 5Y
-22.19%
EBITDA MARGIN AVG 10Y
-17170.99%
EBITDA MARGIN AVG 15Y
-3201.03%
EBITDA MARGIN AVG 20Y
-2205.17%
CURRENT VS TTM AVG
-20.32%
CURRENT VS 3Y AVG
+152.01%
CURRENT VS 5Y AVG
+281.76%
CURRENT VS 10Y AVG
+100.23%
CURRENT VS 15Y AVG
+101.26%
CURRENT VS 20Y AVG
+101.83%
Aurinia Pharmaceuticals Inc.
Market Cap
$2.02B
EBITDA Margin
40.34%
TTM Avg
50.63%
3Y Avg
16.01%
5Y Avg
-22.19%
Market Cap
$2.02B
EBITDA Margin
-3042.18%
TTM Avg
-3200.65%
3Y Avg
-2392.49%
5Y Avg
-2392.49%
Market Cap
$2.01B
EBITDA Margin
1.74%
TTM Avg
-0.52%
3Y Avg
3.36%
5Y Avg
2.51%
Market Cap
$2.05B
EBITDA Margin
7.12%
TTM Avg
6.21%
3Y Avg
-1.19%
5Y Avg
-11.55%
Market Cap
$2.06B
EBITDA Margin
39.14%
TTM Avg
19.43%
3Y Avg
-11.55%
5Y Avg
-189.29%
Market Cap
$1.96B
EBITDA Margin
-13.52%
TTM Avg
-19.53%
3Y Avg
-24.36%
5Y Avg
-23.78%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.02B | 40.34% | 50.63% | 16.01% | -22.19% |
| Immunome, Inc. (IMNM)vs › | $2.02B | -3042.18% | -3200.65% | -2392.49% | -2392.49% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 1.74% | -0.52% | 3.36% | 2.51% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 0.15% | 1.29% | -6.34% | -9.86% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 7.12% | 6.21% | -1.19% | -11.55% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 39.14% | 19.43% | -11.55% | -189.29% |
| Alvotech (ALVO)vs › | $2.07B | 19.79% | 20.20% | -178.47% | -247.76% |
| Azenta, Inc. (AZTA)vs › | $1.97B | 8.41% | 9.50% | 6.21% | 7.73% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -13.52% | -19.53% | -24.36% | -23.78% |
| Absci Corporation (ABSI)vs › | $1.95B | -4034.86% | -3070.57% | -2386.79% | -1872.66% |
Gross Margin
90.4%
EBITDA Margin
40.3%
Operating Margin
37.1%
Net Margin
100.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 61.49% |
| 2026-03-31 | 59.50% |
| 2025-12-31 | 49.41% |
| 2025-09-30 | 47.11% |
| 2025-06-30 | 35.63% |
| 2025-03-31 | 42.75% |
| 2024-12-31 | 5.33% |
| 2024-09-30 | 24.55% |
| 2024-06-30 | 5.82% |
| 2024-03-31 | -11.63% |
| 2023-12-31 | -54.83% |
| 2023-09-30 | -19.83% |
| 2023-06-30 | -37.24% |
| 2023-03-31 | -83.89% |
| 2022-12-31 | -98.05% |
| 2022-09-30 | -15.58% |
| 2022-06-30 | -124.15% |
| 2022-03-31 | -171.30% |
| 2021-12-31 | -136.80% |
| 2021-09-30 | -338.09% |
| 2021-06-30 | -699.18% |
| 2021-03-31 | -5484.35% |
| 2020-12-31 | -15.59% |
| 2020-09-30 | -144182.76% |
| 2020-06-30 | -91531.03% |
| 2020-03-31 | -89206.67% |
| 2019-12-31 | -70720.69% |
| 2019-09-30 | -10270.43% |
| 2019-06-30 | -55410.34% |
| 2019-03-31 | -48340.00% |
| 2018-12-31 | -49337.93% |
| 2018-09-30 | -3653.33% |
| 2018-06-30 | -48058.62% |
| 2018-03-31 | -42160.00% |
| 2017-12-31 | -37993.55% |
| 2017-09-30 | -46303.45% |
| 2017-06-30 | -2941.95% |
| 2017-03-31 | -34587.10% |
| 2016-12-31 | -25533.33% |
| 2016-09-30 | -16219.35% |
| 2016-06-30 | -7612.73% |
| 2016-03-31 | -7824.56% |
| 2015-12-31 | -9054.39% |
| 2015-09-30 | -10515.79% |
| 2015-06-30 | -9642.37% |
| 2015-03-31 | -8351.61% |
| 2014-12-31 | -6516.18% |
| 2014-09-30 | -5329.17% |
| 2014-06-30 | -5914.08% |
| 2014-03-31 | -5005.97% |
| 2013-12-31 | -111.72% |
| 2013-09-30 | -1112.65% |
| 2013-06-30 | -997.70% |
| 2013-03-31 | -840.46% |
| 2012-12-31 | -6313.73% |
| 2012-09-30 | -1687.21% |
| 2012-06-30 | -1921.13% |
| 2012-03-31 | 68.84% |
| 2011-12-31 | -1337.86% |
| 2011-09-30 | -170.13% |
| 2011-06-30 | -1082.56% |
| 2011-03-31 | -1124.63% |
| 2010-12-31 | -615.31% |
| 2010-09-30 | -441.80% |
| 2010-06-30 | -15.48% |
| 2010-03-31 | -47.09% |
| 2009-12-31 | -84.80% |
| 2009-09-30 | -144.36% |
| 2009-06-30 | -331.84% |
| 2009-03-31 | -347.98% |
| 2008-12-31 | -1754.53% |
| 2008-09-30 | -133.46% |
| 2008-06-30 | -940.19% |
| 2008-03-31 | -861.49% |
| 2007-12-31 | -1389.67% |
| 2007-09-30 | -1403.99% |
| 2007-06-30 | -2193.76% |
| 2007-03-31 | -1146.35% |
| 2006-09-30 | -1247.17% |
| 2005-12-31 | 797.66% |
| 2005-09-30 | -283.48% |
| 2005-06-30 | -3217.46% |
| 2005-03-31 | -2191.41% |
| 2004-12-31 | -3128.64% |
| 2004-09-30 | -2364.22% |
| 2004-06-30 | -1291.47% |
| 2004-03-31 | -651.06% |
| 2003-12-31 | -787.25% |
| 2003-09-30 | -1245.75% |
| 2003-06-30 | 31.73% |
| 2003-03-31 | -1382.97% |
| 2002-12-31 | -929.28% |
| 2002-09-30 | 43.92% |
